Evaluation of the screening questionnaire Düsseldorfer Instrument zum Borderline-Screening (abbr: DIBS) for the diagnosis and severity classification of a borderline personality disorder.
- Conditions
- F60.31
- Registration Number
- DRKS00024190
- Lead Sponsor
- VR Klinikum Düsseldorf
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Patients with a diagnosis of borderline personality disorder according to DSM-5 as their primary diagnosis,
- or patients who do not have a diagnosis of borderline personality disorder according to DSM-5, but who have
Have at least one of the following DSM-5 diagnoses: bipolar disorder, schizoaffective disorder,
depression, acute psychosis, schizophrenia, narcissistic personality disorder, histrionic
Personality Disorder, Dependent Personality Disorder, Anxious-Avoidant Personality Disorder,
obsessive-compulsive personality disorder, addiction, PTSD, autism spectrum disorder, eating disorders.
- Sufficient German language skills
- Age between 16-65 years
- Existing ability to give consent or consent from a legal guardian for patients under the age of 18
years
- Voluntary participation
- Age < 16 years
- Pre-diagnosed intellectual deficits or severe language impairment
- Prediagnosed dementia
- Insufficient knowledge of the German language
- Consenting guardianship: Patients with legal guardianship with consenting guardianship are
excluded from the study
- Patients who do not volunteer or whose legal guardians do not give consent
- For patients with borderline personality disorder according to DSM-5: an acute psychosis or psychosis, a history or diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder,
major depression (Hamilton depression scale > 25) or organic affective disorder.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoints of the study are to assess the validity, reliability, and diagnostic accuracy of the initial diagnostic portion of the screener versus the current diagnost. gold standard, the structured clinical interview (using the Structural Clinical Interview for DSM-5 (SCID-5-PD; First et al., 2016)) and the validity, reliability, and accuracy of the severity classifier against an expert assessment of clinical severity according to the Clinical Global Impression-Severity scale (CGI-S; Guy, 1976). The CGI-S is a 7-point scale that asks clinicians to rate the severity of the patient's illness at the time of assessment relative to their previous experience with patients with the same diagnosis.
- Secondary Outcome Measures
Name Time Method